Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies
Over 90% of potential anti-cancer drug candidates results in translational failures in clinical trials. The main reason for this failure can be attributed to the non-accurate pre-clinical models that are being currently used for drug development and in personalised therapies. To ensure that the asse...
Guardado en:
Autores principales: | Andrew M. K. Law, Laura Rodriguez de la Fuente, Thomas J. Grundy, Guocheng Fang, Fatima Valdes-Mora, David Gallego-Ortega |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/95fb65fb5899476aa52b33cf93b7182e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Interplay between Cellular and Non-Cellular Components of the Tumour Microenvironment in Hepatocellular Carcinoma
por: Tamás Sükei, et al.
Publicado: (2021) -
Printing of vessels for small functional tissues – a preliminary study
por: Polley Christian, et al.
Publicado: (2020) -
Advancements and frontiers in nano-based 3D and 4D scaffolds for bone and cartilage tissue engineering
por: Qasim M, et al.
Publicado: (2019) -
Bioprinting Au Natural: The Biologics of Bioinks
por: Kelsey Willson, et al.
Publicado: (2021) -
Editorial: Recent 3D Tumor Models for Testing Immune-Mediated Therapies
por: Jacques Zimmer, et al.
Publicado: (2021)